secwatch.observer — SEC 8-K summary
======================================

Issuer:     Virpax Pharmaceuticals, Inc. (—)
CIK:        0001708331
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001731122-24-001427
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Virpax board member Vanila M. Singh resigns effective Sept 16, 2024
-------------------------------------------------------------------

- Vanila M. Singh, MD, resigned from the Board on September 16, 2024, effective immediately.
- No reason for resignation was provided in the filing.
- No replacement has been announced at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708331/000173112224001427/0001731122-24-001427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708331/000173112224001427/e5951_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer